Smiths Medical needle sheath error leads to recall:
This article was originally published in Clinica
Executive Summary
Smiths Medical is conducting an urgent recall of batches of its Wallace dual lumen oocyte recovery needle sets used in IVF treatment, according to a Medicines and Healthcare products Regulatory Agency (MHRA) device alert, posted on January 27. The recall affects batches manufactured between February and June 2003, which were made with protective sheaths that are too short to cover the needle fully, with a risk that it can penetrate its outer packaging and make the device non-sterile. The MHRA had not received any reports of infections or lost IVF cycles, due to bacterial contamination resulting from the fault.
You may also be interested in...
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.